3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
28
Gastric Adenocarcinoma
4
Sarcopenia
2
Recurrence
1
Peritoneal Neoplasms
1
Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer
1
Osteoporosis
1
Obesity, Abdominal
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Margins of Excision
1
Locally Advanced Gastric Carcinoma
1
Locally Advanced Gastric Cancer
1
Hypertension
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Diabetes Mellitus
1
Coitus
1
Advanced Gastric Cancer
1
Adenocarcinoma
1
Interventions
Fluorouracil
98
Oxaliplatin
94
Leucovorin
86
Irinotecan
70
Gemcitabine
66
Bevacizumab
62
Capecitabine
60
Cetuximab
42
pembrolizumab
38
Cisplatin
31
Nivolumab
25
Drug Therapy
25
130-nm albumin-bound paclitaxel
22
Specimen Handling
20
Folfox protocol
20
Panitumumab
19
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Albumin-Bound Paclitaxel
17
Biopsy
16
IFL protocol
15
Floxuridine
15
Docetaxel
15
Cyclophosphamide
15
Sorafenib
14
regorafenib
12
Erlotinib Hydrochloride
12
aflibercept
11
Radiofrequency Ablation
11
Carboplatin
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Gastrectomy
×
Gastrointestinal
×
Clear all
NCT04574245
2022-10-05
RECORD
Chinese PLA General Hospital
Unknown
3,000 enrolled